ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 146 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,805,000 | -13.0% | 238,335 | +0.9% | 0.01% | -12.5% |
| Q1 2019 | $3,224,000 | +288.4% | 236,220 | +191.6% | 0.01% | +300.0% |
| Q4 2018 | $830,000 | -42.2% | 81,020 | -6.1% | 0.00% | -50.0% |
| Q3 2018 | $1,437,000 | +4.0% | 86,290 | -1.3% | 0.00% | 0.0% |
| Q2 2018 | $1,382,000 | +21.5% | 87,460 | -2.3% | 0.00% | +33.3% |
| Q1 2018 | $1,137,000 | +22.5% | 89,492 | +10.5% | 0.00% | 0.0% |
| Q4 2017 | $928,000 | -2.0% | 81,009 | +4.8% | 0.00% | 0.0% |
| Q3 2017 | $947,000 | +163.8% | 77,286 | +146.8% | 0.00% | +200.0% |
| Q2 2017 | $359,000 | -42.3% | 31,316 | +4.6% | 0.00% | -50.0% |
| Q1 2017 | $622,000 | -3.9% | 29,926 | -3.8% | 0.00% | 0.0% |
| Q4 2016 | $647,000 | -34.9% | 31,121 | +2.6% | 0.00% | -33.3% |
| Q3 2016 | $994,000 | +95.7% | 30,341 | +49.0% | 0.00% | +50.0% |
| Q2 2016 | $508,000 | +21.8% | 20,361 | +19.5% | 0.00% | 0.0% |
| Q1 2016 | $417,000 | – | 17,041 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
| Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
| PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
| Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
| PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
| Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
| CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
| Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |